ERBB2 and breast carcinoma: Unsupervised hierarchical cluster analysis shows that the samples divide into HER2− and HER2+ breast cancer cell lines and that, within these 2 groups, the samples cluster according to palbociclib sensitivity and resistance (Figure 7A).